Form 8-K · Current report
Cardinal Health 8-K, filed Oct 1, 2026
- Filed
- CIK
- 0000721371
- Accession no.
- 0000721371-26-000041
Summary
Cardinal Health entered into a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032, keeping the current scope of distribution services. Cardinal Health reaffirmed its fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60 and its long-term non-GAAP EPS growth guidance of 12% to 14%, with CEO Jason Hollar citing the long-standing partnership with CVS Health.
Key points
- The letter of intent extends Cardinal Health's existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.
- Cardinal Health reaffirmed fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60, representing 13% to 15% growth, and long-term non-GAAP EPS growth guidance of 12% to 14%.
- Further updates may be provided during Cardinal Health's first quarter earnings call on November 5, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01: Regulation FD Disclosure On October 1, 2026, Cardinal Health, Inc. (the “Company”) issued a news release announcing that it had entered into a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032. In connection with this announcement, the Company also reaffirmed its previously issued fiscal year 2027 non-GAAP earnings per share (EPS) guidance range of $12.40 to $12.60 and its long-term non-GAAP EPS growth range guidance of 12% to 14%. A copy of the news release is included as Exhibit 99.1 to this report. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.